Publication Date
9-1-2020
Journal
International Forum of Allergy & Rhinology
Abstract
BACKGROUND: Biologic medications are emerging as options for treating chronic rhinosinusitis with nasal polyps (CRSwNP). Several questions remain regarding patient selection, indications, clinical efficacy, and cost effectiveness.
METHODS: In November 2019, a group of physicians and scientists gathered to consider strategies for future studies regarding biologics. During the discussion, gaps in knowledge highlighted a need for a consensus on the present day use of biologics in polyp patients.
RESULTS: The goal of this guideline is to propose recommendations for the current use of biologics in CRSwNP as new evidence continues to emerge and inform practice.
CONCLUSION: We suggest that physicians evaluate patients on an individual basis and closely monitor for improvement due to the high cost and unknown long-term effects of biologics.
Keywords
chronic rhinosinusitis, medical therapy of chronic rhinosinusitis, endoscopic sinus surgery, topical therapy for chronic rhinosinusitis, guideline
Comments
PMID: 32484603